VivoSim Labs, Inc. Proceeds from Notes Payable
VivoSim Labs, Inc. (VIVS) reported Proceeds from Notes Payable of $4.63 million for the 80-month period ending 2013-12-31, per its 10-Q filed 2014-02-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2014-02-06
- VivoSim Labs, Inc. proceeds from notes payable for the quarter ending 2011-12-31 was $1.50M.
- VivoSim Labs, Inc. proceeds from notes payable for the quarter ending 2011-09-30 was $743.80K.
- VivoSim Labs, Inc. proceeds from notes payable for the quarter ending 2011-06-30 was $138.70K.
- VivoSim Labs, Inc. proceeds from notes payable for the quarter ending 2011-03-31 was $160.00K.
- VivoSim Labs, Inc. proceeds from notes payable for fiscal 2011 was $2.54M, a 156.35% increase from fiscal 2010.
- VivoSim Labs, Inc. proceeds from notes payable for fiscal 2010 was $992.00K.
| Period end | Proceeds from Notes Payable 1 month | Proceeds from Notes Payable 1 month as first filed | Proceeds from Notes Payable 2 month | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 24 month | Proceeds from Notes Payable 47 month | Proceeds from Notes Payable 59 month | Proceeds from Notes Payable 62 month | Proceeds from Notes Payable 65 month | Proceeds from Notes Payable 68 month | Proceeds from Notes Payable 71 month | Proceeds from Notes Payable 74 month | Proceeds from Notes Payable 77 month | Proceeds from Notes Payable 80 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $4.63M 10-Q · filed 2014-02-06 | ||||||||||||||||
| 2013-09-30 | $4.63M 10-Q · filed 2013-11-08 | ||||||||||||||||
| 2013-06-30 | $4.63M 10-Q · filed 2013-08-09 | ||||||||||||||||
| 2013-03-31 | $4.63M 10-KT · filed 2013-05-24 | ||||||||||||||||
| 2012-12-31 | $4.63M 10-K · filed 2013-03-15 | ||||||||||||||||
| 2012-09-30 | $4.63M 10-Q · filed 2012-11-14 | ||||||||||||||||
| 2012-06-30 | $4.63M 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | $4.63M 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2012-02-08 | $1.50M 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-12-31 | $1.50M derived: 10-KT 12 month − 10-Q 9 month · filed 2013-05-24 | $9.50K 10-Q · filed 2012-01-17 | $2.38M derived: sum of 3 quarters · filed 2013-05-24 | $2.54M 10-KT · filed 2013-05-24 | $9.50K 10-Q · filed 2012-01-17 | $2.39M 10-KT · filed 2013-05-24 | |||||||||||
| 2011-09-30 | $743.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $882.50K derived: sum of 2 quarters · filed 2012-11-14 | $1.04M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-08-31 | $740.00K 10-KT · filed 2013-05-24 | ||||||||||||||||
| 2011-06-30 | $138.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $298.70K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $160.00K 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-01-17 | $992.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |